SCWorx Corp (Nasdaq: WORX), a software-as-a-service company specializing in data management solutions for healthcare providers, has announced it has been granted a 180-day extension by the Nasdaq Stock Market to comply with its minimum bid price requirement. This extension comes as the company faces challenges in maintaining its stock price above the $1.00 threshold, as mandated by Nasdaq Listing Rule 5550(a)(2).

1. Extension Details

On October 14, 2025, SCWorx disclosed that it has until April 6, 2026, to achieve compliance with the minimum bid price requirement. This extension allows the company additional time to ensure that its common stock price remains at or above $1.00 per share for at least ten consecutive business days. Should SCWorx meet this condition within the extension period, Nasdaq will confirm compliance, effectively closing the matter.

The company had initially been notified of its non-compliance on April 10, 2025, when it was determined that SCWorx's stock had failed to maintain the minimum bid price for 30 consecutive trading days. Following this notification, SCWorx was provided a deadline of October 7, 2025, to rectify the situation, a deadline it did not meet, leading to the current extension.

2. Conditions for Continued Listing

Importantly, Nasdaq's extension does not affect the current listing status of SCWorx's common stock on The Nasdaq Capital Market under the symbol "WORX." The company must continue to meet other listing requirements, including maintaining a market value of publicly held shares and adhering to additional applicable standards. If SCWorx is unable to meet the minimum bid price by the end of the extension period, it will receive written notification regarding potential delisting. At that point, the company would have the opportunity to appeal the decision to a Nasdaq Hearings Panel, although there is no guarantee of a successful outcome.

3. About SCWorx Corp

SCWorx Corp is at the forefront of revolutionizing healthcare data management through its advanced software solutions. Utilizing machine learning and artificial intelligence, the company has developed a comprehensive data platform that integrates various modules, including Virtual Item Master, data cleansing, contract management, and more. This suite of services is designed to enhance operational efficiency, provide accurate reporting, and ultimately drive cost savings for healthcare providers.

The company’s commitment to data governance and analytics positions it as a critical resource in the healthcare industry, where accurate data management is increasingly vital.

4. Looking Ahead

As SCWorx navigates this challenging period, the focus will be on regaining compliance with Nasdaq's listing requirements. The extension granted by Nasdaq provides a crucial opportunity for the company to stabilize its stock price and ensure its continued presence on the exchange. Stakeholders will be closely monitoring SCWorx's efforts and performance in the coming months as the company works toward meeting the necessary compliance thresholds.

The outcome of SCWorx’s efforts will not only impact its stock price but also reflect on its broader operational strategy in a highly competitive healthcare technology landscape.

Original press release